WASHINGTON, Oct. 23 -- Patent and Trademark Office has issued a notice called: Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comm... Read More
WASHINGTON, Oct. 23 -- Nuclear Regulatory Commission has issued a notice called: US SFR Owner, LLC; Kemmerer Power Station, Unit 1; Final Environmental Impact Statement. The notice was published in t... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219680) titled 'Intervention for Communication Quality of Life in Primary Progressive Aphasia' on Oct. 20. ... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219758) titled 'RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219667) titled 'South Asians With Type 2 Diabetes at Risk for Depression' on Oct. 21. Brief Summary: This ... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219849) titled 'A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With S... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219706) titled 'Dietary Fiber and Time Restricted Eating' on Oct. 20. Brief Summary: This study is seeking... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219602) titled 'A Randomized Phase 3 Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219537) titled 'Pilot Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule' on Oct.... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219563) titled 'Alnuctamab for Refractory SLE (LATTE Study)' on Oct. 20. Brief Summary: This study will as... Read More